Online citations, reference lists, and bibliographies.
← Back to Search

Physicochemical Characterization Of Colloidal Drug Delivery Systems Such As Reverse Micelles, Vesicles, Liquid Crystals And Nanoparticles For Topical Administration.

C. Müller-Goymann
Published 2004 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Topical administration of cosmetics and pharmaceuticals involves a variety of different formulations of which colloidal drug carrier systems are currently of particular interest. After a short introduction of reverse micellar solutions, liquid crystals, vesicles and nanoparticles, appropriate methods of physicochemical characterization are introduced including X-ray diffraction, laser light scattering, electron microscopy, and differential scanning calorimetry. Emphasis is laid on topical applications of the colloidal drug delivery systems (DDS) covered, with the main objective of both sustained drug release and improved stability of DDS.
This paper references
10.1016/S0168-3659(99)00223-0
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties.
V. Jenning (2000)
10.1023/A:1016392407150
Liquid Crystals in Emulsions, Creams, and Gels Containing Ethoxylated Sterols as Surfactant
C. Müller-Goymann (2004)
Multiple lipidic systems: Simple and multiple emulsions and solid lipid nanoparticles in cosmetics
S. Gohla (2002)
10.1016/S0939-6411(03)00138-3
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
F. Lallemand (2003)
10.1016/0025-5408(75)90226-3
Liquid crystals and plastic crystals: Volume 1. Edited by G. W. Gray and P. A. Winsor. Pp. 383. Halsted Press, New York, 1974. Price: $32.50
G. Brown (1975)
Thermal behaviour and solubility of fenoprofen calcium
T. Rades (1996)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1007/S003960050379
Effects of oligonucleotide adsorption on the physicochemical characteristics of a nanoparticle-based model delivery system for antisense drugs
N. Götting (1999)
10.1007/BF00656934
Mutual interactions between nonionic surfactants and gelatin — investigations in cubic liquid crystalline systems and micellar systems
W. Schütze (1992)
Binary, diclofenac diethylamine-water systems : micelles, vesicles and lyotropic liquid crystals
K. Kriwet (1993)
10.1016/0378-5173(86)90112-2
Interaction of lidocaine and lidocaine-HCl with the liquid crystal structure of topical preparations
C. Müller-Goymann (1986)
10.1016/S0378-5173(99)00426-3
Comparison of wax and glyceride solid lipid nanoparticles (SLN).
V. Jenning (2000)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
Investigations on the occlusive properties of solid lipid nanoparticles (SLN).
S. Wissing (2001)
Textures of liquid crystals
D. Demus (1978)
10.1016/S0168-3659(02)00056-1
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration.
S. Wissing (2002)
10.1007/BF01397893
Organische Salze der Flufenaminsäure: Eine neue Stoffklasse zur Bildung lyotroper Mesophasen in wäßrigen Systemen
T. Eckert (1981)
10.1016/0370-1573(80)90041-1
Surfactant-water liquid crystal phases
G. Tiddy (1980)
10.1016/S0378-5173(02)00684-1
Cosmetic applications for solid lipid nanoparticles (SLN).
S. Wissing (2003)
10.1023/A:1015871809313
Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense Oligonucleotides
C. Chavany (2004)
Novel colloidal drug delivery systems.
K. Westesen (2001)
10.1023/A:1025065418309
Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study
K. Jores (2004)
10.1209/0295-5075/24/1/009
Rheology of lyotropic lamellar phases
D. Roux (1993)
10.1021/J100382A057
Evaluation of viscosity measurements of dilute solutions of ionic surfactants forming rod-shaped micelles
H. Kohler (1990)
10.1007/S00396-002-0851-4
Structural properties of nonionic surfactant/glycerol/paraffin lyotropic liquid crystals
M. Makai (2003)
10.1016/S0378-5173(02)00220-X
The influence of the crystallinity of lipid nanoparticles on their occlusive properties.
S. Wissing (2002)
10.1016/S0378-5173(02)00219-3
The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles.
S. Wissing (2002)
10.1023/A:1012127829032
In Vivo and In Vitro Diclofenac Sodium Evaluation After Rectal Application of Soft Gelatine Capsules Enabling Application Induced Transformation (AIT) into a Semisolid System of Liquid Crystals (SSLC) for Controlled Release
A. Schneeweis (2004)
10.1016/S0378-5173(02)00180-1
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
10.1007/978-94-010-9628-7
The physical chemistry of membranes
Brian L. Silver (1985)
10.3891/ACTA.CHEM.SCAND.22-3209
Some isotropic mesophases in systems containing amphiphilic components
K. Fontell (1968)
10.1016/S0378-5173(00)00378-1
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
10.1201/b19309
Encyclopedia of Pharmaceutical Technology
J. Swarbrick (2006)
Lyotroper Mesomorphismus von Arzneistoffen unter besonderer Berücksichtigung der Profene
H.-J. Hamann (1987)
10.1080/713817583
Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization
V. Jenning (2002)
10.1007/BF00654663
The effect of particle concentration on zeta potential in extremely dilute solutions
K. B. Medrzycka (1991)
10.1517/14656566.5.1.195
Verteporfin ocular photodynamic therapy
S. Bakri (2004)
10.1023/A:1015847628047
Parenteral Peptide Formulations: Chemical and Physical Properties of Native Luteinizing Hormone-Releasing Hormone (LHRH) and Hydrophobic Analogues in Aqueous Solution
M. F. Powell (2004)
10.1016/S0378-5173(99)00423-8
Solubilization of timolol maleate in reversed micellar systems. Measurement of particle size using SAXS and PCS.
S. Mackeben (2000)
10.1103/PHYSREVA.45.8683
High-precision heat-capacity study of phase transitions in a lyotropic liquid crystal.
Shin (1992)
10.1159/000211149
Feasibility of measuring the bioavailability of topical ibuprofen in commercial formulations using drug content in epidermis and a methyl nicotinate skin inflammation assay.
P. Treffel (1993)
10.1023/A:1016270724413
Preparation and Physicochemical Characterization of Aqueous Dispersions of Coenzyme Q10 Nanoparticles
B. Siekmann (2004)
10.1016/S0378-5173(00)00462-2
Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: a 1H-NMR study
V. Jenning (2000)
10.1046/j.1467-2494.2001.00087.x
A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles
S. Wissing (2001)
10.1081/BIO-100001254
A REVERSE MICROEMULSION POLYMERIZATION METHOD FOR PREPARATION OF BIOADHESIVE POLYACRYLIC ACID NANOPARTICLES FOR MUCOSAL DRUG DELIVERY: LOADING AND RELEASE OF TIMOLOL MALEATE
T. de (2001)
10.1016/0168-3659(93)90042-4
Sustained release from reverse micellar solutions by phase transformations into lamellar liquid crystals
C. Müller-Goymann (1993)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
10.1007/978-3-642-58712-2_5
Anwendung lyotroper Flüssigkristalle in Pharmazie und Medizin
C. Müller-Goymann (1999)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1080/15421407308083381
Mesomorphism in the System Disodium Chromoglycate-Water
N. H. Hartshorne (1973)
10.1002/JPS.2600840415
Preparation and Structure of a Water‐in‐Oil Cream Containing Lipid Nanoparticles
T. D. Vringer (1995)
10.1002/9783527620760
Handbook of liquid crystals
H. Kelker (1980)
Halbfeste emulsionsähnliche Zustände
C. Müller-Goymann (1984)
10.1080/02652040010000361
Encapsulation of retinoids in solid lipid nanoparticles (SLN).
V. Jenning (2001)
10.1016/S0378-5173(99)00413-5
Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
C. A. S. Maia (2000)
10.1080/02652040010018056
Production of solid lipid nanoparticles (SLN): scaling up feasibilities
A. Dingler (2002)
10.1016/S0939-6411(99)00075-2
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
V. Jenning (2000)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/S0939-6411(02)00130-3
Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.
M. Schubert (2003)
Characterization of a commercial liposome spray.
T. Rades (1997)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1107/S0365110X60001564
La structure des colloïdes d'association. I. Les phases liquide–cristallines des systèmes amphiphile–eau
V. Luzzati (1960)
10.1002/JPS.2600820513
Formation and characterization of cyclosporine-loaded nanoparticles.
M. Guzmán (1993)
10.1002/JPS.2600731042
Liquid crystals as a potential ointment vehicle.
S. Wahlgren (1984)



This paper is referenced by
10.1080/10408347.2018.1489216
A Critical Review of the Properties and Analytical Methods for the Determination of Curcumin in Biological and Pharmaceutical Matrices
Renata Carolina Alves (2019)
10.5604/01.3001.0010.7137
Nanostructures: General information. The use of nanoobjects in medicine and cosmetology
P. Dębek (2017)
10.1080/03639045.2019.1576721
Some observations on the liquid crystalline and gel behaviors of aqueous dispersions of a prodrug
L. Tao (2019)
CONTENDO ANFOTERICINA B PARA ADMINISTRAÇÃO ORAL
M. Filho (2006)
Desenvolvimento e caracterização físico-química de sistemas líquido cristalinos contendo palmitato de retinol: quantificação química, avaliação da atividade antioxidante, estudos de liberação e bioadesão in vitro
Paula Lacerda Oliveira (2011)
10.1021/CG300160C
Supramolecular Organization of Neutral and Ionic Forms of Pharmaceutically Relevant Glycyrrhizic Acid—Amphiphile Self-Assembly and Inclusion of Small Drug Molecules
E. Tykarska (2012)
10.1016/J.MOLSTRUC.2018.07.019
Photophysical features of coumarin 120 in reverse micelles
Ebru Bozkurt (2018)
10.1016/j.micron.2012.07.008
Electron microscopy of pharmaceutical systems.
V. Klang (2013)
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE FARMÁCIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS
P. Alegre (2005)
10.1517/17425247.2013.783008
Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery
M. Lapteva (2013)
10.1039/C0SM00965B
Molecular dynamics simulation of a polysorbate 80 micelle in water
A. Amani (2011)
A Multi-Scale Hybrid Nanoparticle Platform with Controlled Cellular Interaction and Targeting Kinetics
Suhair Sunoqrot (2013)
10.3390/pharmaceutics5010115
Analytical Electron Microscopy for Characterization of Fluid or Semi-Solid Multiphase Systems Containing Nanoparticulate Material
V. Klang (2013)
10.1016/J.JDDST.2016.04.010
Development of mucoadhesive and thermosensitive eyedrops to improve the ophthalmic bioavailability of ibuprofen
Hugo Almeida (2016)
10.1016/B978-0-323-47720-8.00023-7
Design and development of pharmaceutical microprocesses in the production of nanomedicine
Méndez Norma Angélica Noguéz (2017)
10.1016/J.JDDST.2017.08.016
Monoacyl-phospatidylcholine nanostructured lipid carriers: Influence of lipid and surfactant content on in vitro skin permeation of flufenamic acid and fluconazole
M. Wolf (2017)
10.1002/JPS.21157
Physicochemical characterisation of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid.
Nadja Grüning (2008)
PRODUÇÃO E CARACTERIZAÇÃO DE NANOCÁPSULAS CONTENDO TRANS-ANETOL E AVALIAÇÃO IN VITRO DA CAPACIDADE ANTIOXIDANTE
Ariane Schneider Colusso (2016)
10.1002/jbm.a.34453
Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Mohd Abul Kalam (2013)
10.1016/J.JDDST.2017.09.005
Liquid crystalline microspheres for 5-fluorouracil specific release
Roberta Cassano (2017)
10.1016/J.COLSURFB.2006.12.002
Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide.
S. Y. Fung (2007)
10.1080/01932691.2017.1283511
Structural properties of N-dodecyl-N,N-dimethyl-3-ammonio-1-propane-sulfonate micelle in water by molecular dynamics simulation
Guangmiao Qu (2017)
10.1002/ADMI.201600781
Structural Reinforcement through Liquid Encapsulation
A. Chipara (2017)
10.5772/INTECHOPEN.74156
Recent Dispersion Technology Using Liquid Crystal
Y. Yamashita (2018)
10.1016/j.ijpharm.2019.118712
Lamellar liquid crystals maintain keratinocytes' membrane fluidity: an AFM qualitative and quantitative study.
Mirjam Gosenca Matjaž (2019)
Liposome: method of preparation, advantages, evaluation and its application
Bhupendra Pradhan (2015)
NOVEL DRUG DELIVERY SYSTEM IN HERBAL'S
Kharat Amol (2014)
Avaliação da permeação cutânea in vitro de sistemas nanoestruturados contendo ácido kójico
M. L. Gonçalez (2012)
10.1016/j.ejpb.2009.03.002
A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ.
Y. Zhao (2009)
10.1201/B19038
Handbook of Encapsulation and Controlled Release
M. Mishra (2015)
10.1039/C0SM01409E
Soft nanoparticles (thermo-responsive nanogels and bicelles) with biotechnological applications: from synthesis to simulation through colloidal characterization
J. M. Ramos (2011)
Application of lipid nanoparticles for the delivery of methotrexate for dermal treatment of psoriasis
M. Pinto (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar